Two Year SAVE Outcomes: 2.0 mg ranibizumab for recalcitrant neovascular AMD
- PMID: 24001533
- DOI: 10.1016/j.ophtha.2013.06.030
Two Year SAVE Outcomes: 2.0 mg ranibizumab for recalcitrant neovascular AMD
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical